|
SEPSECS expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.788970E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.398400E-01 |
| Normal-vs-Stage2 |
6.707400E-01 |
| Normal-vs-Stage3 |
3.575400E-03 |
| Normal-vs-Stage4 |
3.82020000000427E-05 |
| Stage1-vs-Stage2 |
8.216200E-01 |
| Stage1-vs-Stage3 |
1.362580E-03 |
| Stage1-vs-Stage4 |
1.62384999999876E-05 |
| Stage2-vs-Stage3 |
9.106100E-02 |
| Stage2-vs-Stage4 |
2.045700E-02 |
| Stage3-vs-Stage4 |
1.861610E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.333000E-01 |
| Normal-vs-AfricanAmerican |
5.975700E-02 |
| Normal-vs-Asian |
5.085000E-01 |
| Caucasian-vs-AfricanAmerican |
2.355800E-01 |
| Caucasian-vs-Asian |
5.683000E-01 |
| AfricanAmerican-vs-Asian |
2.318400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.696800E-01 |
| Normal-vs-Female |
2.183400E-01 |
| Male-vs-Female |
7.674800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.754500E-02 |
| Normal-vs-Age(41-60Yrs) |
8.022400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.627580E-02 |
| Normal-vs-Age(81-100Yrs) |
6.121800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.068200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.556600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.330200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.390200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.252200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.319200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.027400E-01 |
| Normal-vs-Grade 2 |
3.344600E-01 |
| Normal-vs-Grade 3 |
2.209000E-01 |
| Normal-vs-Grade 4 |
1.75759407028409E-12 |
| Grade 1-vs-Grade 2 |
4.958600E-01 |
| Grade 1-vs-Grade 3 |
6.749600E-02 |
| Grade 1-vs-Grade 4 |
9.388500E-04 |
| Grade 2-vs-Grade 3 |
4.860500E-02 |
| Grade 2-vs-Grade 4 |
1.30895294603306E-13 |
| Grade 3-vs-Grade 4 |
3.27790017351504E-11 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.625300E-04 |
| Normal-vs-ccB subtype |
2.31329999600405E-08 |
| ccA subtype-vs-ccB subtype |
1.62625468647093E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.424400E-01 |
| Normal-vs-N1 |
9.198700E-03 |
| N0-vs-N1 |
6.162400E-02 |
|
|
